Screening for Individual Susceptibility Factors to Immersion Pulmonary Edema
NCT ID: NCT05049889
Last Updated: 2022-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
63 participants
INTERVENTIONAL
2022-08-17
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Edema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary Hypertension
NCT02548091
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
NCT05050617
Risk Stratification for Patients Presenting With Acute Pulmonary Embolism (PE)
NCT00562042
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
NCT00621075
Role of Echocardiography in Pulmonary Embolism
NCT04020250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
* 1 group of divers with a history of immersion pulmonary edema
* 1 group of matched divers without a history of immersion pulmonary edema
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
History of Immersion Pulmonary Edema
The participants will have 2 visits:
At visit 1 (Day 0), the participants will perform a terrestrial exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.
At visit 2 (Day 7), the participants will perform a swimming exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.
Terrestrial exercise
At visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load.
During this exercise, continuous data collection will be performed:
* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.
Swimming exercise
At visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel.
During this exercise, continuous data collection will be performed:
* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.
Transthoracic cardiac ultrasound
The participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.
Transthoracic pulmonary ultrasound
The participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.
Blood collection
Several blood samples will be collected at visit 1 and 2.
No history of Immersion Pulmonary Edema
The participants will have 2 visits:
At visit 1 (Day 0), the participants will perform a terrestrial exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.
At visit 2 (Day 7), the participants will perform a swimming exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.
Terrestrial exercise
At visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load.
During this exercise, continuous data collection will be performed:
* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.
Swimming exercise
At visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel.
During this exercise, continuous data collection will be performed:
* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.
Transthoracic cardiac ultrasound
The participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.
Transthoracic pulmonary ultrasound
The participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.
Blood collection
Several blood samples will be collected at visit 1 and 2.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Terrestrial exercise
At visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load.
During this exercise, continuous data collection will be performed:
* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.
Swimming exercise
At visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel.
During this exercise, continuous data collection will be performed:
* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.
Transthoracic cardiac ultrasound
The participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.
Transthoracic pulmonary ultrasound
The participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.
Blood collection
Several blood samples will be collected at visit 1 and 2.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 18 and 60
* Good physical condition (able to run/swim for 30 minutes at a constant pace).
Exclusion Criteria
* Persons with contraindications to physical exercise and/or scuba diving
* Pregnant or breastfeeding women
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Equipe Résidente de Recherche Subaquatique Opérationnelle
Toulon, , France
Hôpital d'Instruction des Armées Sainte-Anne
Toulon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01225-36
Identifier Type: OTHER
Identifier Source: secondary_id
2019PBMD07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.